Yizhen Pang

1.Pang Yizhen†, Zhao Liang†, Luo Zuoming, Hao Bing, Wu Hua, Lin Qin, Sun Long, Chen Haojun*. Comparison of 68Ga-FAPI and 18F-FDG Uptake in Gastric, Duodenal, and Colorectal Cancers. Radiology. 2021 Feb;298(2):393-402. 2.Chen Haojun†*, Zhao Liang†, Pang Yizhen†, Shi Jiyun†, Gao Haonan, Sun Yining, Chen Jianhao, Fu Hao, Cai Jiayu, Yu Lingyu, Zeng Ru, Sun Long, Wu Hua, Wang Zhanxiang*, Wang Fan*. 68Ga-MY6349 PET/CT imaging to assess Trop2 expression in multiple types of cancer. J Clin Invest. 2024 Nov 7;135(1):e185408. 3.Pang Yizhen†, Zhao Liang†, Fang Jianyang†, Chen Jianhao, Meng Lingxin, Sun Long, Wu Hua, Guo Zhide*, Lin Qin, Chen Haojun*. Development of FAPI Tetramers to Improve Tumor Uptake and Efficacy of FAPI Radioligand Therapy. J Nucl Med. 2023 Sep;64(9):1449-1455. 4.Pang Yizhen†, Zhao Liang†, Meng Tinghua†, Xu Weizhi, Lin Qin, Wu Hua, Zhang Jingjing, Chen Xiaoyuan*, Sun Long*, Chen Haojun*. PET Imaging of Fibroblast Activation Protein in Various Types of Cancer Using 68Ga-FAP-2286: Comparison with 18F-FDG and 68Ga-FAPI-46 in a Single-Center, Prospective Study. J Nucl Med. 2023 Mar;64(3):386-394. 5.Zhao Liang†, Pang Yizhen†, Zhou Yangfan†, Chen Jianhao†, Fu Hao, Guo Wei, Xu Weizhi, Xue Xin, Su Guoqiang, Sun Long, Wu Hua, Zhang Jingjing, Wang Zhanxiang, Lin Qin*, Chen Xiaoyuan*, Chen Haojun*. Antitumor efficacy and potential mechanism of FAP-targeted radioligand therapy combined with immune checkpoint blockade. Signal Transduct Target Ther. 2024 Jun 3;9(1):142. 6.Pang Yizhen†, Zhao Long†, Shang Qihang†, Meng Tinghua, Zhao Liang, Feng Liuxing, Wang Shuangjia, Guo Ping, Wu Xiurong, Lin Qin, Wu Hua, Huang Weipeng*, Sun Long*, Chen Haojun*.Positron emission tomography and computed tomography with [68Ga]Ga-fibroblast activation protein inhibitors improves tumor detection and staging in patients with pancreatic cancer. Eur J Nucl Med Mol Imaging. 2022;49(4):1322-1337.